Analytics

Devin Chandler is sales engineer in the Custom Products Group at AeroGo.

Articles

It’s crucial to consider the optimal handling systems for cleanroom and other lab environments.

Finding the Right System for Moving Pharmaceutical Machinery

The BioProfile FAST CDV is a fully automated viable cell density and viability analyzer.

Nova Biomedical Launches Cell Density and Viability Analyzer

Pfizer and Gero have partnered to discover potential therapeutic targets for fibrotic diseases using machine learning technology.

Pfizer and Gero Form Collaboration to Discover Potential Targets for Fibrotic Diseases

The collaboration between AbbVie and Anima Biotech will combine Anima's mRNA Lightning technology platform with AbbVie's extensive expertise in oncology and immunology.

AbbVie and Anima Biotech Partner on Discovery and Development of mRNA Biology Modulators

Mark Eller, PhD, is senior vice-president (SVP) of Research and Development at Aria Pharmaceuticals. Eller has held several vice-president/SVP roles leading teams from discovery through approval at large and mid-sized pharma companies, including Jazz, Quintiles (now IQVIA), and HMR (now Sanofi). Eller is co-inventor on 30 patents and has led health authority presentations and negotiations, including six FDA advisory committee meetings. He has co-authored numerous scientific publications and served as an adjunct professor of Pharmaceutics at the University of Cincinnati. Eller received his Pharmacy degree and PhD in Pharmaceutics from the University of Iowa.

Advancing the use of AI to understand the whole of a disease can reveal drug development insights that lead to drug discovery breakthroughs.

Technology as a New Evolution in Fighting Disease

Feliza Mirasol is the science editor for 

PK/PD studies are a crucial tool in the successful development of biologics.

PK/PD Studies Prove Critical for mAb Development

The launch of Discovery Life Sciences’ new Proteomic Services Division offers a single source for large-scale population studies, biobank characterization, and multi-omic biomarker analysis.

Discovery Life Sciences Now Offers Large-Scale Proteomic Services

The R&D analytical solutions will consist of analytical lab services that use USP’s in-house scientific expertise and state-of-the-art facilities at the USP Advanced Manufacturing Technology Lab in Richmond and the USP headquarters facility in Rockville, Md.

USP Advanced Manufacturing Technology Lab Opens for Further Developments in R&D Analytics

Wai-Chi Man is IC/SP product marketing manager at Thermo Fisher Scientific.

One can improve method precision and productivity by replacing one step in sample preparation with an automated approach.



Automating Glycoprotein Analysis for Vaccine Manufacture

Kenji Tabata, PhD, is senior vice-president, head of Discovery Intelligence, Applied Research & Operations, at Japan-based pharmaceutical company Astellas.

Advancing digital transformation can significantly reduce R&D costs and shorten drug discovery timelines.

Laboratory Equipment and Instruments